Citi Pharma Ltd banner
C

Citi Pharma Ltd
KAR:CPHL

Watchlist Manager
Citi Pharma Ltd
KAR:CPHL
Watchlist
Price: 72.86 PKR -0.12%
Market Cap: Rs16.6B

Wall St Price Targets

CPHL Price Targets Summary
Citi Pharma Ltd

There are no price targets for CPHL.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Citi Pharma Ltd Competitors:
Price Targets
THFF
First Financial Corp
-4% Downside
EVER
EverQuote Inc
7% Upside

Revenue
Forecast

23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
23% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Revenue has been 23%.

Gross Profit
Forecast

27% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
27% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is -10%.

Operating Income
Forecast

29% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
29% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 29%. The projected CAGR for the next 3 years is -12%.

Pre-Tax Income
Forecast

28% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
28% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 28%. The projected CAGR for the next 3 years is -10%.

Net Income
Forecast

26% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
26% / Year
Past Growth
-12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 4 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is -12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CPHL's stock price target?
Not Available

CPHL does not have any price targets made by Wall Street professionals.

What is the Gross Profit forecast for Citi Pharma Ltd?
Projected CAGR
-10%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is -10%.

What is the Operating Income forecast for Citi Pharma Ltd?
Projected CAGR
-12%

Over the last 4 years, the compound annual growth rate for Operating Income has been 29%. The projected CAGR for the next 3 years is -12%.

What is the Pre-Tax Income forecast for Citi Pharma Ltd?
Projected CAGR
-10%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 28%. The projected CAGR for the next 3 years is -10%.

What is the Net Income forecast for Citi Pharma Ltd?
Projected CAGR
-12%

Over the last 4 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is -12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett